Meeting Posters

Misclassification of treatment-resistant depression: Addressing trial eligibility by evaluating antidepressant discontinuation (Abstract)

Garneni
2025 Autumn Conference – Includes Joint Day with ECNP

Precision psychiatry in MDD: Finite mixture modeling of nelivaptan response suggests distinct responder classes (Abstract)

zu Eulenburg
2025 Autumn Conference – Includes Joint Day with ECNP

COMP 005 and COMP 006: Approaches to challenges in randomized-controlled clinical trials with psychedelics (Abstract)

Hewitt
2025 Autumn Conference – Includes Joint Day with ECNP

Ensuring data integrity through calibrated central quality reviewers (Abstract)

Roy
2025 Autumn Conference – Includes Joint Day with ECNP

A composite Rater Performance Index (RPI) to enhance rater oversight in depression clinical trials (Abstract)

Khan
2025 Autumn Conference – Includes Joint Day with ECNP

From paper to precision: Improved MADRS scoring accuracy with eCOA implementation (Abstract)

Rumerman
2025 Autumn Conference – Includes Joint Day with ECNP

Methodological considerations and regional differences in risk-based data monitoring in global depression trials (Abstract)

Engler
2025 Autumn Conference – Includes Joint Day with ECNP

The prevalence and relationship of anxiety and depression in acute schizophrenia clinical trials (Abstract)

Kott
2025 Autumn Conference – Includes Joint Day with ECNP

Comparison of percent change from baseline using 10 vs. 30 items of the PANSS in an adult, acutely exacerbated clinical trial population with schizophrenia (Abstract)

Daniel
2025 Autumn Conference – Includes Joint Day with ECNP

Impact of rater change in schizophrenia clinical trials using the PANSS (Abstract)

Echevarria
2025 Autumn Conference – Includes Joint Day with ECNP

Effect of demographics on EEG/ERP biomarkers of schizophrenia: Analysis across four pharma-sponsored CNS clinical trials (Abstract)

Korolev
2025 Autumn Conference – Includes Joint Day with ECNP

Optimizing composite endpoints: A machine learning approach to improve signal detection in clinical trials for neurodegenerative diseases (Abstract)

Zhuang
21st Annual Scientific Meeting

Optimize clinical trial design to study nutraceutical correction of essential fatty acid ratio for weight restoration and maintenance in anorexia nervosa (Abstract)

Yang
21st Annual Scientific Meeting

Device agnostic digital Digit Symbol Substitution Test (DSST) for use on smartphones and tablets (Abstract)

Xu
21st Annual Scientific Meeting

Generative AI-enhanced language analysis for early detection of psychosis risk (Abstract)

Wolff
21st Annual Scientific Meeting

Evaluating the relationship among esketamine monotherapy efficacy and dissociation in patients with treatment-resistant depression (Abstract)

Williams
21st Annual Scientific Meeting

Development of a Bayesian progression model to assess the impact of an intervention on the progression of multiple system atrophy (Abstract)

Wiedemann
21st Annual Scientific Meeting

Acceptability and validity of the smartphone-administered version of the Cogstate Brief Battery in middle-aged and older adults of the Healthy Brain Project (Abstract)

Wacker
21st Annual Scientific Meeting

Practice effects in digital semantic verbal fluency assessments improve detection of cognitive impairments in an older-age memory clinic population (Abstract)

Tröger
21st Annual Scientific Meeting

Connectome predictive modelling of PTSD symptom severity (Abstract)

Tamman
21st Annual Scientific Meeting